Dirk Rades1, Jon Cacicedo2, Antonio J Conde-Moreno3, Barbara Segedin4, Darejan Lomidze5, Raquel Ciervide6, Niels H Hollaender7, Steven E Schild8. 1. Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. rades.dirk@gmx.net. 2. Department of Radiation Oncology, Cruces University Hospital/Biocruces Health Research Institute, Barakaldo, Spain. 3. Department of Radiation Oncology, University and Polytechnic Hospital La Fe, Valencia, Spain. 4. Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia. 5. Radiation Oncology Department, HTMC University Clinic Tbilisi, Tbilisi, Georgia. 6. Department of Radiation Oncology, University Hospital HM Hospitales, Sanchinarro, Madrid, Spain. 7. Department of Oncology and Palliative Units, Zealand University Hospital, Naestved, Denmark. 8. Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Abstract
BACKGROUND: In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 × 5 Gy in 1 week to 10 × 3 Gy in 2 weeks in a prospective cohort. METHODS: Forty patients receiving 5 × 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 × 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). RESULTS: After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 × 5 Gy and 87% after 10 × 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 × 5 Gy and 85% after 10 × 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). CONCLUSIONS: 5 × 5 Gy in 1 week appeared similarly effective as 10 × 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 × 5 Gy and 10 × 3 Gy. Trial registration clinicaltrials.gov NCT03070431. Registered 27 February 2017.
BACKGROUND: In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 × 5 Gy in 1 week to 10 × 3 Gy in 2 weeks in a prospective cohort. METHODS: Forty patients receiving 5 × 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 × 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). RESULTS: After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 × 5 Gy and 87% after 10 × 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 × 5 Gy and 85% after 10 × 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). CONCLUSIONS: 5 × 5 Gy in 1 week appeared similarly effective as 10 × 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 × 5 Gy and 10 × 3 Gy. Trial registration clinicaltrials.gov NCT03070431. Registered 27 February 2017.
Entities:
Keywords:
Ambulatory status; Local progression-free survival; Metastatic spinal cord compression; Motor function; Overall survival; Radiotherapy alone
Authors: Samuel Ryu; Jack Rock; Rajan Jain; Mei Lu; Joseph Anderson; Jian-Yue Jin; Mark Rosenblum; Benjamin Movsas; Jae Ho Kim Journal: Cancer Date: 2010-05-01 Impact factor: 6.860
Authors: Khaled Dibs; Dukagjin M Blakaj; Rahul N Prasad; Alexander Olausson; Eric C Bourekas; Daniel Boulter; Ahmet S Ayan; Eric Cochran; William S Marras; Prasath Mageswaran; Evan Thomas; Hyeri Lee; John Grecula; Raju R Raval; Ehud Mendel; Thomas Scharschmidt; Russell Lonser; Arnab Chakravarti; James B Elder; Joshua D Palmer Journal: Front Oncol Date: 2022-06-08 Impact factor: 5.738
Authors: Jacob Y Shin; Noah J Mathis; Neil Ari Wijetunga; Divya Yerramilli; Daniel S Higginson; Adam M Schmitt; Daniel R Gomez; Yoshiya J Yamada; Jonathan T Yang Journal: Adv Radiat Oncol Date: 2022-02-04
Authors: Giuseppe Roberto Giammalva; Gianluca Ferini; Fabio Torregrossa; Lara Brunasso; Sofia Musso; Umberto Emanuele Benigno; Rosa Maria Gerardi; Lapo Bonosi; Roberta Costanzo; Federica Paolini; Paolo Palmisciano; Giuseppe Emmanuele Umana; Rina Di Bonaventura; Carmelo Lucio Sturiale; Domenico Gerardo Iacopino; Rosario Maugeri Journal: Life (Basel) Date: 2022-04-12